KSN 2026

Industry Symposium 1 (Otsuka) June 11 (Thu) 12:00-12:40 | Room 2 (GBR 102)

Chair(s)	Hyeong Cheon Park (Gangnam Severance Hospital, Yonsei University)
Speaker(s)	From Guidelines to Practice: Real-World Experience with Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Semin Cho (Chung-Ang University Gwangmyeong Hospital)

Industry Symposium 2 (Boehringer Ingelheim) June 11 (Thu) 12:00-12:40 | Room 3 (GBR 103)

Chair(s)	Jung Eun Lee (Samsung Medical Center, Sungkyunkwan University)
Speaker(s)	Slowing Progressive Kidney Disease with Empagliflozin: The Earlier the Better? Merlin Thomas (Monash University)

Industry Symposium 3 (GSK) June 12 (Fri) 12:00-12:40 | Room 1 (GBR 101)

Chair(s)	TBD
Speaker(s)	TBD

Industry Symposium 4 (DKSH) June 12 (Fri) 12:00-12:40 | Room 2 (GBR 102)

Chair(s)	TBD
Speaker(s)	Optimal Management of SHPT in Dialysis Patients: Clinical Benefits and Experience with Evocalcet Hirotaka Komaba (Tokai University School of Medicine)

Industry Symposium 5 (Daewon) June 12 (Fri) 12:00-12:40 | Room 3 (GBR 103)

Chair(s)	TBD
Speaker(s)	Clinical Efficacy and Evidence of Renamezin in CKD & DKD TBD

Industry Symposium 6 (FME) June 12 (Fri) 12:00-12:40 | Room 4 (203)

Chair(s)	TBD
Speaker(s)	Next-Generation Dialysis Membranes: What Clinicians Should Know TBD

Industry Symposium 7 (AstraZeneca) June 13 (Sat) 11:50-12:30 | Room 1 (GBR 101)

Chair(s)	TBD
Speaker(s)	Managing the Ongoing Risk of Hyperkalemia with Sodium Zirconium Cyclosilicate (SZC), LOKELMA Jamie Dwyer (University of Utah Health)

Industry Symposium 8 (AstraZeneca) June 13 (Sat) 11:50-12:30 | Room 2 (GBR 102)

Chair(s)	TBD
Speaker(s)	Managing the Ongoing Risk of Hyperkalemia with Sodium Zirconium Cyclosilicate (SZC), LOKELMA Huang-Yu Yang (Chang Gung Memorial Hospital)